Most recents posts
CMR2024, London, UK, on January 25–27, 2024
What a fantastic location the organizers had chosen for this meeting in between Westminster Abbey, Downing street and the Big Ben. The meeting hosted over 3000 participants, and 50 % of those were there for the first time! Our focus was in the first day of the iCMR pre/conference joining with a vendor pitch. We enjoyed you visiting our booth to see and try our new TRACKR software which is intended as a navigation tool for your current or future ICMR procedures. Have you missed the live case? Go to the Whova app, and select in the Agenda Live Case and you will part of our interventional MRI world. Start using your scanner as cathlab!! We provide the devices and the software!
MEVAR consortium review meeting
The Acronym MEVAR is derived from MRI guided Endovascular Repair.
MEVAR aims to develop an MRI compatible stentgraft for aneurysm repair.
In this consortium 4 German SME’s (Peragraft, AM Filament, PMH, Nano4Imaging) and 3 Universities (UKSH, UKA and Uni Duisburg) join efforts in a highly interdisciplinary effort.
The recent review meeting has shown the significant progress that the project is making with regard to stent production with MagnaFy marked components to allow precise stenting.
Our DELIVR grant is now moving into a crucial phase in which we will apply the instruments developed by N4I (micro guidewire and MagnaFy marked catheters) will be applied to performed CT-MRI guided SIRT in pigs over the next months.
We are happy to share that at the mid-term review meeting on April 11 th we showed our current TRACKR software prototype and had fruitful discussions on the use of MRI imaging data to further develop and validate our deep learning algorithms for MRI guidance.
For more information on the project click here.
Collaboration Siemens Healthineers
Nano4Imaging GmbH, a leader in real time interventional cardiac magnetic resonance (iCMR) solutions, is pleased to announce that it has signed a Letter of Intent (LOI) with Siemens Healthineers that provides Nano4Imaging the ability to develop and subsequently deploy the Company’s new TRACKR software as a guiding system on the Siemens Healthineers MAGNETOM Magnetic Resonance Imaging (MRI) systems.
The LOI aims to provide Nano4Imaging the ability to connect its AI based endovascular guiding software TRACKR to Siemens Healthineers MAGNETOM systems. This connection is made possible by a CE-labeled software interface from Siemens Healthineers called “Access-i”, which is available for Siemens Healthineers MAGNETOM systems such as MAGNETOM Sola and Vida. In addition, the interface would also allow using the TRACKR software for guidance of catheters from other vendors equipped with Nano4Imaging MagnaFy markers on Siemens Healthineers MAGNETOM systems, including their recently introduced 0.55T scanner MAGNETOM Free.Max.
The LOI further aims to provide the opportunity for current iCMR sites using Siemens Healthineers MAGNETOM systems to extend their interventional MRI toolkit with Nano4Imaging prototype TRACKR software beginning in 2024. Their input will be used to customize the TRACKR prototype software to exact clinical needs and performance.
Rudolf Schulze Vohren, CEO Nano4Imaging, summarizes as follows: “This collaboration with Siemens Healthineers will advance the application of our TRACKR platform for the development of new endovascular treatment modalities, especially in partnership with many device OEMs. For the benefit of many patients and hospital professionals.”
Robert Krieg, VP MR Advanced Solutions & Therapy, Siemens Healthineers, stated: “Siemens Healthineers is excited to engage in this development partnership with Nano4Imaging, since it has the potential to complement our software and hardware offerings in MR guided interventions for our clinical partners”.
Commenting on the collaboration with Siemens Healthineers, Rudolf Schulze Vohren continued: “The TRACKR software is a result of the close partnership we have with Siemens Healthineers, and we are very pleased with how our partnership continues to grow and mature.